22 research outputs found
An unusual case of metastasis to the left side of the heart: a case report
<p>Abstract</p> <p>Introduction</p> <p>Cardiac metastases are found in six to 20% of autopsies of patients with malignant neoplasm. The most common neoplasms that metastasize to the heart are malignant melanoma, lymphoma, and leukemia, but the relative numbers are greater with breast and lung cancers, reflecting the most common incidence of these cancers.</p> <p>Case presentation</p> <p>A 60-year-old Hispanic man presented to our hospital after being transferred from an outside hospital for workup and evaluation of an adrenal mass of the abdomen and pelvis, found on computed tomography. His chief complaint upon admission was altered mental status. Physical examination was unremarkable. He was alert and oriented and had a dry and non-erythematous oropharynx, and bilateral diffuse wheezing on lung examination. Computed tomography of the chest showed multiple hypodense lesions in the left ventricular myocardium, suggestive of metastases. There were also tiny sub-centimeter nodular densities in the right upper and lower lobes. Adrenal glands contained hypodense lesions, which showed characteristic adenocarcinomatous malignant cells.</p> <p>Conclusion</p> <p>Cancers which have metastasized to the heart are found in six to 20% of patients with malignant neoplasms. The right side of the heart is more commonly involved in metastasis. This study is unusual in that a tumor of an unknown primary origin had metastasized to the left side of the heart.</p
Brief Report - Azithromycin as Treatment for Cryptosporidiosis in Human Immunodeficiency Virus Disease
Background: Cryptosporidiosis caused by the protozoa Cryptosporidium,
is the common cause of diarrhoea in Acquired Immune Deficiency Syndrome
(AIDS). Aim: To study the efficacy of short-term azithromycin in the
management of cryptosporidiosis. Settings and Design: Randomised,
controlled trial. Material and Methods: All consecutive patients
infected with Human Immunodeficiency Virus (HIV), who were positive for
cryptosporidial oocysts were taken for this prospective randomised
study. Result: Short-term azithromycin treatment for cryptosporidial
diarrhoea in AIDS patients was associated with good clinical
improvement but parasitological benefit was doubtful. All 13 patients,
who had symptoms of cryptosporidiosis, symptomatically improved with 5
days of treatment with azithromycin and became asymptomatic after 7
days of antibiotic, but stool sample was positive for cryptosporidium
even after 7 days of therapy. After 14 days of treatment with
azithromycin in 13 patients, in five patients stool was free of
cryptosporidial oocyst. The drug was well tolerated in all the
patients. Conclusion: Short-term azithromycin can be used as a safe and
effective treatment for symptomatic Cryptosporidiosis but not effective
in eradicating Cryptosporidial infection. (J Postgrad Med
2002;48:179-181
Bilateral coronary - pulmonary fistulae, diagnosed by transoesophageal echocardiogram.
Bilateral coronary artery fistulae to pulmonary artery is a rare condition. We diagnosed this condition by transoesophageal echocardiogram and successfully treated with surgery
In a trial of the use of miltefosine to treat HIVârelated cryptosporidiosis in Zambian adults, extreme metabolic disturbances contribute to high mortality
Treatment of cryptosporidiosis in immunocompromised individuals: systematic review and meta-analysis
Cryptosporidium is a common cause of gastroenteritis and is associated with severe life-threatening illness among immunocompromised individuals. This review aimed to assess the efficacy of interventions for the treatment and prevention of cryptosporidiosis among immunocompromised patients. A search of Medline, Embase and other electronic databases was carried out up to August 2005. Two reviewers independently extracted data and assessed study quality. The relative risk for each intervention was calculated. Seven trials involving 169 participants were included. Nitazoxanide and paramomycin were associated with a relative risk (RR) of reduction in the duration and frequency of diarrhoea of 0.83 [95% confidence interval (CI) 0.36, 1.94] and 0.74 (95% CI 0.42, 1.31), respectively, showing no evidence of effectiveness. Nitazoxanide led to significant evidence of oocyst clearance compared with placebo with a RR of 0.52 (95% CI 0.30, 0.91). The effect was not significant for HIV-seropositive participants (RR 0.71, 95% CI 0.36, 1.37). HIV-seronegative participants on nitazoxanide had a significantly higher relative risk of achieving parasitological clearance of 0.26 (95% CI 0.09, 0.80) based on a single study. No other intervention was associated with either a reduction in diarrhoea, mortality or a significant parasitological response. This review confirms the absence of evidence for effective agents in the management of cryptosporidiosis. The results indicate that nitaxozanide reduces load of parasites and may be useful in immunocompetent individuals. The absence of effective therapy highlights the importance of preventive interventions in this group of patients